BigHat Biosciences SMI AI in drug discovery March 2021

Поділитися
Вставка
  • Опубліковано 20 гру 2024

КОМЕНТАРІ • 1

  • @Freddychao
    @Freddychao 3 роки тому +1

    nice approach to building a new antibody therapy. My questions are 1. what are the advantages of AI/ML assisted and designed antibodies over that produced from natural viral stimulation or a vaccine? 2. Nanobodies are becoming more popular due to its simplicity, is there a reason BihHat start with the traditional antibody vs the nano?